Biomarker Core for Alzheimer's Disease Biomarkers
Official title: Biomarker Core
Funded at Northern California Institute/res/edu · NIH-11395218 · Data updated 2026-11-12
A dedicated Biomarker Core supports Alzheimer’s research by managing and standardizing blood and CSF samples and by identifying the best methods to measure disease biomarkers in people with Alzheimer’s and related conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northern California Institute/res/edu NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 30, 2004 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $618,226 |
| NIH project number | 5U19AG024904-19 |
| Project ID | NIH-11395218 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with Alzheimer’s disease dementia or related Alzheimer syndrome who participate in studies that involve biofluid samples and biomarker testing.
✕Less likely to help
People not involved in biomarker or sample-based studies may not benefit directly from this core.
What this research studies
This program centralizes the handling of biofluid samples collected from participants, ensuring they are stored, processed, and annotated consistently. It also coordinates studies to standardize how biofluid samples are collected and measured for Alzheimer’s biomarkers, especially plasma biomarkers. In addition, it plans to compare different measurement platforms and select the most reliable method for plasma biomarker testing in Alzheimer’s research. The core works with researchers to transfer samples to approved studies and to implement chosen biomarker testing methods in the lab.
Why it matters
Potential benefit: If successful, this core could improve the accuracy and comparability of Alzheimer’s biomarkers, speeding up diagnosis and tracking of disease progression.
How similar studies have gone: Previous biomarker cores have helped standardize sample handling and improved reproducibility of biomarker measurements in Alzheimer’s research.
Where this research is happening
-
Northern California Institute/res/edu
San Francisco, United States Active
Researchers
- Principal investigator: Shaw, Leslie Michael — Northern California Institute/res/edu
- Study coordinator: Shaw, Leslie Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.